Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Neff

Showing results (531-540 of 547) with videos related to

Pageof 55
Sort By:
HGG Advances|January 20, 2022
An activating germline <i>IDH1</i> variant associated with a tumor entity characterized by unilateral and bilateral chondrosarcoma of the mastoidPatrick R Blackburn, Jodi M Carter, Devin Oglesbee, et al.
Journal of Neurosurgery|January 22, 2026
Defining clinically significant tumor size in sporadic vestibular schwannoma to inform timing of radiosurgery during wait-and-scan management: further evidence supporting size threshold surveillanceMatthew L Carlson, John P Marinelli, Eric E Babajanian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Acute lung injury induced by lipopolysaccharide is independent of complement activationDaniel Rittirsch, Michael A Flierl, Danielle E Day, et al.
The American Journal of Pathology|March 4, 2005
Relationship of acute lung inflammatory injury to Fas/FasL systemThomas A Neff, Ren-Feng Guo, Simona B Neff, et al.
Journal of Neurosurgery|January 22, 2026
Long-term tumor control after Gamma Knife radiosurgery for sporadic vestibular schwannomaJohn P Marinelli, Ghazal S Daher, Karl R Khandalavala, et al.
Nature Medicine|May 23, 2006
Generation of C5a in the absence of C3: a new complement activation pathwayMarkus Huber-Lang, J Vidya Sarma, Firas S Zetoune, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 11, 2002
Protection of innate immunity by C5aR antagonist in septic miceMarkus S Huber-Lang, Niels C Riedeman, J Vidya Sarma, et al.
Laryngoscope Investigative Otolaryngology|October 20, 2021
Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomasD Bradley Welling, Katharine A Collier, Sarah S Burns, et al.
Scientific Reports|January 4, 2017
Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitorM Flinspach, Q Xu, A D Piekarz, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|January 11, 2024
Pathophysiology of Facial Nerve Stimulation and Its Implications for Electrical Stimulation in Cochlear ImplantsAniket A Saoji, Melissa D DeJong, Natasha J Bertsch, et al.
Pageof 55

Showing results (531-540 of 547) with videos related to

Sort By:
Pageof 55
HGG Advances|January 20, 2022
An activating germline <i>IDH1</i> variant associated with a tumor entity characterized by unilateral and bilateral chondrosarcoma of the mastoidPatrick R Blackburn, Jodi M Carter, Devin Oglesbee, et al.
Journal of Neurosurgery|January 22, 2026
Defining clinically significant tumor size in sporadic vestibular schwannoma to inform timing of radiosurgery during wait-and-scan management: further evidence supporting size threshold surveillanceMatthew L Carlson, John P Marinelli, Eric E Babajanian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Acute lung injury induced by lipopolysaccharide is independent of complement activationDaniel Rittirsch, Michael A Flierl, Danielle E Day, et al.
The American Journal of Pathology|March 4, 2005
Relationship of acute lung inflammatory injury to Fas/FasL systemThomas A Neff, Ren-Feng Guo, Simona B Neff, et al.
Journal of Neurosurgery|January 22, 2026
Long-term tumor control after Gamma Knife radiosurgery for sporadic vestibular schwannomaJohn P Marinelli, Ghazal S Daher, Karl R Khandalavala, et al.
Nature Medicine|May 23, 2006
Generation of C5a in the absence of C3: a new complement activation pathwayMarkus Huber-Lang, J Vidya Sarma, Firas S Zetoune, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 11, 2002
Protection of innate immunity by C5aR antagonist in septic miceMarkus S Huber-Lang, Niels C Riedeman, J Vidya Sarma, et al.
Laryngoscope Investigative Otolaryngology|October 20, 2021
Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomasD Bradley Welling, Katharine A Collier, Sarah S Burns, et al.
Scientific Reports|January 4, 2017
Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitorM Flinspach, Q Xu, A D Piekarz, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|January 11, 2024
Pathophysiology of Facial Nerve Stimulation and Its Implications for Electrical Stimulation in Cochlear ImplantsAniket A Saoji, Melissa D DeJong, Natasha J Bertsch, et al.
Pageof 55